Posters - Clinical research — ASN Events

Posters - Clinical research — ASN Events

Posters - Clinical research

Clinical Research

DENOSUMAB induced Hypocalcaemia in Advanced cancers at the Top End; Severity and Management (#167)

Long-Term Survival in Patients with Metastatic Melanoma who Received Ipilimumab in Four Phase II Trials (#168)

Survival Analysis with 5 years of Follow-Up in a Phase III Study of Ipilimumab and Dacarbazine in Metastatic Melanoma (#169)

RCT of Colonic Stent Insertion vs. Surgical Decompression for Patients with Malignant Incurable Large Bowel Obstruction (#170)

Monitoring clinical studies – improving quality (#171)

Belinda Fazekas

Evaluation of an Education Program to Facilitate Patient Adherence, Toxicity Monitoring and Promote Safety and Wellbeing in the Self Administration of Oral Chemotherapy in the Home Setting (#172)

A Drug-Interaction Study of Effects of Calcium and Magnesium Infusions on Oxaliplatin Pharmacokinetics, Motor Nerve Hyperexcitability and Acute Neurotoxicity Symptoms in Colorectal Cancer Patients (#173)

Catherine H Han

Retrospective Review of Hypersensitivity Reactions to Paclitaxel with Oral Versus Intravenous Dexamethasone, Antihistamine and H2-Antagonist Premedication. (#174)

Granulocytic Sarcoma of the Bladder as the Sole Manifestation of Acute Myelogenous Leukemia: a case report and literature review (#175)

Abdel Nasser Hosein

Development of Guidelines to Inform the Content of Summarized Patient Information Forms (SPIFs) Regarding Cancer-Related, Clinical Trials (#176)

Survival of Patients with Resected Cerebral Metastases from Gastrointestinal Cancers (#177)

A Pilot Study of a Healthy Lifestyle Self-Management Intervention with Cancer Survivors (#178)

Late Effects of Oxaliplatin-induced peripheral Neuropathy (LEON) (#179)

CHARM Utility study (#180)

Monitoring and treatment of hypomagnesaemia in patients receiving cetuximab (#181)

Ipilimumab Retreatment Following Induction Therapy: The Expanded Access Program (EAP) Experience (#182)

A Prospective Study of Anti-Mullerian Hormone (AMH) As a Potential Predictor of Chemotherapy-Induced Menopause: Preliminary Results. (#183)

An introduction to ICCon - Inherited Cancer Connect Partnership (#184)

Gillian Mitchell

Physical Activity (PA) Participation for Women with Ovarian Cancer (#185)

Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes after Positive Sentinel Lymph Node Biopsy in Melanoma Patients: Westmead Melanoma Unit Experience and a Review of Literature (#186)

Vinayak Nagaraja

Metastatic central nervous system recurrence in breast cancer: Impact of tumour sub-type (#187)

Brent O'Carrigan

The Prostate Cancer Journey: Results of an Online Survey of Men and their Partners. (#188)

Kevin O'Shaughnessy

Impaired Sexual Function and Prostate Cancer; A Mixed Method Investigation into the Experiences of Men and their Partners (#189)

Kevin O'Shaughnessy

Audit of Patient Selection and Protocols for Prostate Cancer Active Surveillance in South Australia (#190)

Lovelace Osei-Tutu

Qualitative Results of the LEON study: Late Effects of Oxaliplatin-Induced Peripheral Neuropathy (#191)

Incidence of gastrointestinal toxicity with capecitabine monotherapy in metastatic breast and metastatic colorectal cancer patients (#192)

Barriers to Recruitment for a Post-Cancer Fatigue Intervention Study - The TOPS Trial. (#193)

Carolina Sandler

Effectiveness and safety of first-line ipilimumab (IPI) 3mg/kg therapy for advanced melanoma (AM): Evidence from a U.S. multisite retrospective chart review (#194)

Hypocalcaemia in patients with metastatic bone disease (MBD) receiving denosumab (#195)

Richard H De Boer

Meta-Analysis of Progression-Free Survival Impact of Biological Therapy in Relapsed Metastatic Colorectal Cancer (#196)